SCHEMBL10035368

SCHEMBL10035368

CC(C)OB(OC(C)C)c1cc2ccccc2c2c1oc1ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 4/20 0.33
HTT P42858 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 5/20 0.32
MAOA P21397 2/20 0.32
PPARG P37231 1/20 0.32
NCOA2 Q15596 1/20 0.32
NCOA1 Q15788 1/20 0.32
HSD17B10 Q99714 2/20 0.32
CREBBP Q92793 1/20 0.32
HPGD P15428 2/20 0.32
TP53 P04637 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
KDM4E B2RXH2 3/20 0.32
GAA P10253 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10035365 0.85 TDP1 (0.39) TDP1L3MBTL1LMNAMEN1KMT2A
SCHEMBL10035371 0.81 TDP1 (0.36) TDP1L3MBTL1LMNAHTTMEN1
SCHEMBL10035366 0.81 L3MBTL1 (0.36) TDP1L3MBTL1LMNAHTTALDH1A1
SCHEMBL9950614 0.80 KDM4E (0.42) TDP1L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL30555481 0.80 KDM4E (0.42) TDP1L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL10035370 0.79 MAOB (0.36) TDP1L3MBTL1LMNAHTTALDH1A1
SCHEMBL10035375 0.78 L3MBTL1 (0.34) TDP1L3MBTL1LMNAHTTALDH1A1
SCHEMBL10035367 0.77 CDC25A (0.39) TDP1L3MBTL1HTTKMT2AALDH1A1
SCHEMBL10035369 0.76 FAAH (0.37) TDP1L3MBTL1HTTKMT2AALDH1A1
SCHEMBL10035372 0.75 FAAH (0.39) KMT2AALDH1A1HSD17B10TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674117-B2 Organoboron compound and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-18 US disclosed
US-8674117-B2 Organoboron compound and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-18 US disclosed
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same CYP2B6, CBR3, CBR1 TDP1 4009/4885L3MBTL1 2201/4885LMNA 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.